TMCLIFE

0.675

-0.015 (-2.2%)

OTHERS TMC LIFE SCIENCES BERHAD ("TMC" OR "THE COMPANY") - ISSUANCE OF S$175,000,000 4.05% NOTES DUE 2025 BY THOMSON MEDICAL GROUP LIMITED ("TMGL")

TMC LIFE SCIENCES BERHAD

Type Announcement
Subject OTHERS
Description
TMC LIFE SCIENCES BERHAD ("TMC" OR "THE COMPANY") - ISSUANCE OF S$175,000,000 4.05% NOTES DUE 2025 BY THOMSON MEDICAL GROUP LIMITED ("TMGL")

The Board of Directors of TMC wishes to inform that TMGL, the holding company of TMC had on 20 January 2020 announced on the Singapore Exchange that TMGL has launched and priced S$175,000,000 in aggregate principal amount of 4.05% notes due 2025 (the "Series 002 Notes"). The Series 002 Notes will be issued by TMGL pursuant to the S$500,000,000 Multicurrency Debt Issuance Programme established by TMGL on 28 June 2019. DBS Bank Ltd., Maybank Kim Eng Securities Pte. Ltd. and Standard Chartered Bank (Singapore) Limited have been appointed as the joint lead managers and joint bookrunners in relation to the Series 002 Notes.

 

Please refer to the link below for the detail announcement in respect of the above matter which was released by TMGL on Singapore Exchange:

 

https://links.sgx.com/1.0.0/corporate-announcements/PB4942WF9WEBA4F9/0a65148ed3fe44da92d98f490bee64967d0b4a681d93e24c49748116001953e0

 

This announcement is dated 22 January 2020.






Announcement Info

Company Name TMC LIFE SCIENCES BERHAD
Stock Name TMCLIFE
Date Announced 22 Jan 2020
Category General Announcement for PLC
Reference Number GA1-21012020-00041